IL249219A0 - Use of scoizolaricirsinol diglucoside (sdgs) and similar compounds to protect against radiation and chemical damage - Google Patents

Use of scoizolaricirsinol diglucoside (sdgs) and similar compounds to protect against radiation and chemical damage

Info

Publication number
IL249219A0
IL249219A0 IL249219A IL24921916A IL249219A0 IL 249219 A0 IL249219 A0 IL 249219A0 IL 249219 A IL249219 A IL 249219A IL 24921916 A IL24921916 A IL 24921916A IL 249219 A0 IL249219 A0 IL 249219A0
Authority
IL
Israel
Prior art keywords
sdgs
protection against
related compounds
chemical damage
against radiation
Prior art date
Application number
IL249219A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of IL249219A0 publication Critical patent/IL249219A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL249219A 2014-05-30 2016-11-27 Use of scoizolaricirsinol diglucoside (sdgs) and similar compounds to protect against radiation and chemical damage IL249219A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462005330P 2014-05-30 2014-05-30
US201562101296P 2015-01-08 2015-01-08
PCT/US2015/033501 WO2015184441A2 (en) 2014-05-30 2015-06-01 USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION AND CHEMICAL DAMAGE

Publications (1)

Publication Number Publication Date
IL249219A0 true IL249219A0 (en) 2017-02-28

Family

ID=54700083

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249219A IL249219A0 (en) 2014-05-30 2016-11-27 Use of scoizolaricirsinol diglucoside (sdgs) and similar compounds to protect against radiation and chemical damage

Country Status (9)

Country Link
EP (1) EP3148560A4 (enExample)
JP (2) JP2017520620A (enExample)
KR (1) KR20170010019A (enExample)
CN (2) CN107155304A (enExample)
AU (2) AU2015266614A1 (enExample)
CA (1) CA2950744A1 (enExample)
IL (1) IL249219A0 (enExample)
MA (1) MA39899A (enExample)
WO (1) WO2015184441A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071746B2 (en) 2016-06-07 2021-07-27 The Trustees Of The University Of Pennsylvania Compositions and methods for protecting organs from ischemia/reperfusion injury associated with transplantation
EP3606325B1 (en) * 2017-04-03 2024-09-04 Gusto Global, LLC Rational design of microbial-based biotherapeutics
US20200268779A1 (en) * 2017-09-27 2020-08-27 The Trustees Of The University Of Pennsylvania USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION-INDUCED CARDIOVASCULAR DYSFUNCTION
US20210128596A1 (en) * 2017-09-27 2021-05-06 University Of Pennsylvania Compositions and methods for treating septic cardiomyopathy
EP3843557B1 (en) * 2018-08-31 2023-09-20 Innophos, LLC An extract of anacardium occidentale for use in treating oxidation induced dna damage
CN116850162A (zh) * 2023-08-08 2023-10-10 南通大学附属医院 肠二醇在制备治疗放射性肠炎药物中的应用
CN121094806B (zh) * 2025-11-07 2026-02-24 深圳鼎智通讯股份有限公司 一种Android SoftPOS可信应用方法以及应用系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486126B1 (en) * 1999-06-30 2002-11-26 University Of Saskatchewan Technologies Incorporated Antioxidant activity in SDG metabolites
EP1414436A1 (en) * 2000-06-14 2004-05-06 Alla Shapiro Radioprotective agents
CN100365005C (zh) * 2006-03-02 2008-01-30 江南大学 一种从亚麻籽中提取纯化开环异落叶松树脂酚二葡萄糖苷的方法
US20070293458A1 (en) * 2006-06-16 2007-12-20 Ip-6 Research Inc. Prevention of nuclear, solar, and other radiation-induced tissue damage
US10449224B2 (en) * 2007-05-25 2019-10-22 The Trustees Of The University Of Pennsylvania Flaxseed lignan complex, methods of using and compositions thereof
AU2009279676C1 (en) * 2008-08-07 2015-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Radioprotectants targeting thrombospondin-1 and CD47
CN101759731B (zh) * 2008-12-25 2011-10-19 中国科学院兰州化学物理研究所 亚麻籽胶和开环异落叶松树脂酚二葡萄糖苷的提取方法
PT3007557T (pt) * 2013-06-10 2018-11-09 Scripps Research Inst Preparação do diglucosídeo (s,s)-secoisolariciresinol e do diglucosídeo (r,r)-secoisolariciresinol

Also Published As

Publication number Publication date
EP3148560A2 (en) 2017-04-05
AU2015266614A1 (en) 2016-12-15
WO2015184441A3 (en) 2016-03-10
CA2950744A1 (en) 2015-12-03
CN112336736A (zh) 2021-02-09
AU2020270469A1 (en) 2020-12-17
JP2017520620A (ja) 2017-07-27
WO2015184441A9 (en) 2016-01-21
MA39899A (fr) 2021-05-26
EP3148560A4 (en) 2018-04-25
WO2015184441A2 (en) 2015-12-03
CN107155304A (zh) 2017-09-12
JP2020121987A (ja) 2020-08-13
KR20170010019A (ko) 2017-01-25

Similar Documents

Publication Publication Date Title
GB2558826B (en) Mitigation of anti-sandbox malware techniques
EP3161714A4 (en) Mitigation of malware
IL248158B (en) Conjugated bicyclic substances containing aryl or heteroaryl errors and their use as irak4 inhibitors
GB201720994D0 (en) Protection of sensitive data
IL249663B (en) A process for the preparation of modified oxiranes and triazoles
IL249219A0 (en) Use of scoizolaricirsinol diglucoside (sdgs) and similar compounds to protect against radiation and chemical damage
IL285077A (en) Compounds for the treatment of cancer
DK3209673T3 (en) Mixtures of HMOs
IL247410A0 (en) Preparations and methods for the treatment and prevention of weight gain caused by an antipsychotic drug
EP3314509A4 (en) Mitigation of malware
PL3236476T3 (pl) Kurtyna ochronna przeciw promieniowaniu
SG11201710455UA (en) Cosmetic for protection against ultraviolet radiation
PL3223905T3 (pl) Maska do dozymetrii promieniowania
GB201517002D0 (en) Personal protection device
GB2543602B (en) Mitigation of anti-sandbox malware techniques
GB2547865B (en) Personal protection device
ITUB20154000A1 (it) Dispositivo di protezione per serratura
LT3489849T (lt) Įėjimo į sistemą procesų apsauga
IL257780A (en) Use of secoisolariciresinol diglucosides (sdgs) and related compounds for protection against radiation damage
PT3340975T (pt) Formulação para o tratamento de acne
GB201407829D0 (en) Shock isolation protection of sensitive components
TWM490246U (en) Protection structure of article-placing container
ZA201704589B (en) Compounds for the treatment of cancer